<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Animal models of diseases are essential for therapeutic target validation, drug discovery and development </plain></SENT>
<SENT sid="1" pm="."><plain>Increasing evidence has demonstrated the importance of <z:mp ids='MP_0001845'>inflammation</z:mp> in <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>Here, murine models of vena cava <z:mp ids='MP_0005048'>thrombosis</z:mp> and carotid <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo> augmented by <z:chebi fb="0" ids="16412">lipopolysaccharide</z:chebi> (LPS) were established and characterized to study the association between <z:mp ids='MP_0001845'>inflammation</z:mp> and <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>MATERIALS AND METHODS: Murine (C57BL/6 mice) models of <z:chebi fb="2" ids="30808">ferric chloride</z:chebi> (FeCl(3))-induced carotid arterial and vena cava <z:mp ids='MP_0005048'>thrombosis</z:mp> were established </plain></SENT>
<SENT sid="4" pm="."><plain><z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">Thrombus</z:e> formation was measured indirectly by Doppler blood flow (i.e., clot functional interference with blood flow) in the <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo> model and directly by protein content of the clot in the <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> model </plain></SENT>
<SENT sid="5" pm="."><plain>An optimal concentration of FeCl(3) was defined to induce <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> formation and used to study the effects of LPS (i.e., a well-known inflammatory stimulus under these conditions) </plain></SENT>
<SENT sid="6" pm="."><plain>Real-time polymerase chain reaction (PCR) was used to examine the effect of LPS on TNFalpha and IL-1beta <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression in <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> formation </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: Dose-dependent analysis demonstrated that 2 mg/kg, i.p., LPS provided a maximal prothrombotic effect in 2.5% <z:chebi fb="2" ids="30808">ferric chloride</z:chebi>-induced vena cava <z:mp ids='MP_0005048'>thrombosis</z:mp>, with a 60% increase in <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> size (n=8, p&lt;0.05) compared to vehicle treatment </plain></SENT>
<SENT sid="8" pm="."><plain>In contrast, 2 mg/kg LPS had no significant effect on <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> formation in a more severe, 3.5% FeCl(3)-induced vena cava <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="9" pm="."><plain>A similar prothrombotic effect was observed for LPS in 2.5% FeCl(3)-induced carotid <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo> model </plain></SENT>
<SENT sid="10" pm="."><plain>Treatment of 2 mg/kg LPS significantly augmented <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo> immediately (between 5-30 minutes) following FeCl(3) injury as assessed by change of Doppler blood flow (n=8, p&lt;0.05) </plain></SENT>
<SENT sid="11" pm="."><plain>Real-time PCR demonstrated significant induction of TNFalpha and IL-1beta <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression in the <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> formation in the vessels in response to LPS challenge </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSION: These data demonstrate that LPS augments <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> formation in <z:hpo ids='HP_0011009'>acute</z:hpo> vascular injury and that LPS-augmented <z:mp ids='MP_0005048'>thrombosis</z:mp> might be a useful tool to study the relationship between <z:mp ids='MP_0001845'>inflammation</z:mp> and <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
</text></document>